Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Metronidazole 💬1件: Metronidazole (2-methyl-5-nitroimidazole-1-ethanol)3件: Flagyl; Metronidazol; METRONIDAZOLE--7件: 46, 51, 63, 94, 96, 97, 291 💬
2 Ethanolamine oleate 💬
(Ethanolamine oleate (USAN))		1件: Ethanolamine oleate (Ethanolamine oleate)1件: Ethanolamine oleate--1件: 279 💬
3 Dipivefrin 💬1件: Dipivefrin (1--2-methylamino-1-ethanol)2件: Dipivefrin; Dipivefrine9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬 		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 6 💬
4 Ethanol 💬
(Ethanol (JP18), Ethanol (TN))		1件: Ethanol (Fiberlay Ethanol Disposable Gel Disinfectant)3件: Alcohol; Ethanol; PREDNISONE--5件: 58, 97, 279, 280, 298 💬
5 Clenbuterol 💬1件: Clenbuterol (1--2-tert-butylamino-ethanol)1件: Clenbuterol1件: ADRB2 💬 9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 1, 2, 6, 256 💬
6 Deanol 💬1件: Deanol (2-ethanol)1件: Deanol--1件: 6 💬
7 Hydroxychloroquine 💬1件: Hydroxychloroquine (2-ethanol)3件: Hydroxychloroquine; HYDROXYCHLOROQUINE SULFATE; PLAQUENIL--27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
8 Palmidrol 💬1件: Palmidrol (Palmitoyl ethanolamide)1件: Palmitoylethanolamide--1件: 2 💬